Your browser doesn't support javascript.
Chronic heart diseases as the most prevalent comorbidities among deaths by COVID-19 in Brazil.
Pachiega, Julianne; Afonso, Alexandre José Dos Santos; Sinhorin, Géssica Thaís; Alencar, Bianca Teshima de; Araújo, Marta Dos Santos Miranda de; Longhi, Fabiana Gulin; Zanetti, Andernice Dos Santos; Espinosa, Omar Ariel.
  • Pachiega J; Universidade do Estado de Mato Grosso, Faculdade de Ciências da Saúde, Departamento de Medicina, Cáceres, Mato Grosso, Brazil.
  • Afonso AJDS; Universidade do Estado de Mato Grosso, Faculdade de Ciências da Saúde, Departamento de Medicina, Cáceres, Mato Grosso, Brazil.
  • Sinhorin GT; Universidade do Estado de Mato Grosso, Faculdade de Ciências da Saúde, Departamento de Medicina, Cáceres, Mato Grosso, Brazil.
  • Alencar BT; Universidade do Estado de Mato Grosso, Faculdade de Ciências da Saúde, Departamento de Enfermagem, Cáceres, Mato Grosso, Brazil.
  • Araújo MDSM; Universidade do Estado de Mato Grosso, Faculdade de Ciências Agrárias e Biológicas, Programa de Pós-Graduação em Ciências Ambientais, Cáceres, Mato Grosso, Brazil.
  • Longhi FG; Centro de Excelência do Instituto Joanna Briggs, Centro Brasileiro para o Cuidado à Saúde Informado por Evidências, São Paulo, São Paulo, Brazil.
  • Zanetti ADS; Universidade do Estado de Mato Grosso, Faculdade de Ciências Agrárias e Biológicas, Programa de Pós-Graduação em Ciências Ambientais, Cáceres, Mato Grosso, Brazil.
  • Espinosa OA; Faculdade do Pantanal, Cáceres, Mato Grosso, Brazil.
Rev Inst Med Trop Sao Paulo ; 62: e45, 2020.
Article in English | MEDLINE | ID: covidwho-622435
ABSTRACT
Age, sex and presence of comorbidities are risk factors associated with COVID-19. Hypertension, diabetes and heart disease are the most common comorbidities in patients with COVID-19. The objective of this study was to estimate the prevalence of patients with comorbidities who died of COVID-19 in Brazil. Searches of data were carried out on the official pages of the 26 State health departments and the federal district. The random-effect method was used to calculate the prevalence of patients with comorbidities who died. From the beginning of the pandemic in Brazil until May 20, 2020, 276,703 cases of COVID-19 were notified in Brazil, 6.4% died, 58.6% of whom were male. The prevalence of comorbidities among deaths was 83% (95% CI 79 - 87), with heart disease and diabetes being the most prevalent. To our knowledge, this study represents the first large analysis of cases of patients with confirmed COVID-19 in Brazil. There is a high prevalence of comorbidities (83%) among patients who died from COVID-19 in Brazil, with heart disease being the most prevalent. This is important considering the possible secondary effects produced by drugs such as hydroxychloroquine.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus / Heart Diseases Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Rev Inst Med Trop Sao Paulo Year: 2020 Document Type: Article Affiliation country: S1678-9946202062045

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus / Heart Diseases Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Rev Inst Med Trop Sao Paulo Year: 2020 Document Type: Article Affiliation country: S1678-9946202062045